OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
80 hedge funds and large institutions have $379M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
16% more funds holding
Funds holding: 69 → 80 (+11)
Holders
80
Holding in Top 10
4
Calls
$2.25M
Puts
$452K
Top Buyers
| 1 | +$29.2M | |
| 2 | +$9.31M | |
| 3 | +$3.6M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$3.32M |
| 5 |
First Manhattan
New York
|
+$2.62M |
Top Sellers
| 1 | -$7.58M | |
| 2 | -$1.6M | |
| 3 | -$1.17M | |
| 4 |
Morgan Stanley
New York
|
-$825K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$586K |